spectral-ai.com - MDAI Total Company Value-to-Revenue Ratio

spectral-ai.com (MDAI) - corporate logo

Spectral AI, Inc. (MDAI) develops benchmark AI systems for wound diagnostics, leveraging unique data and FDA approval. The precision of the DeepView platform ensures a stable technical process, although slow clinical adoption and reliance on grants create risks. The company's price-to-sales trend on the GURU.Markets chart visualizes these factors, and the current value is recorded at 3434.60.

Spectral AI, Inc. (MDAI) EV/Sales Multiple: for the period 11/23/2025 - 11/19/2026

Financial and market metric breakdowns for Spectral AI, Inc. (MDAI)

- share price and consensus valuation forecast:
Fundamental company valuation:MDAI, spectral-ai.com
Flagship merchandise of Spectral AI Inc.

Steady revenue growth for Spectral AI, Inc. driven by the scaling of B2B subscriptions during the industry's digital transformation creates a solid foundation for capitalization. The Enterprise Value to Sales (EV/Sales) ratio allows for a valuation of the company regardless of debt load, helping investors determine fair pricing boundaries and avoid value traps by analyzing changes in the EV/Sales multiple.